118 related articles for article (PubMed ID: 2782273)
1. The nifedipine gastrointestinal therapeutic system in the treatment of hypertension.
Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
Am J Cardiol; 1989 Sep; 64(11):65F-69F. PubMed ID: 2782273
[TBL] [Abstract][Full Text] [Related]
2. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg.
Toal CB;
Clin Ther; 2001 Jan; 23(1):87-96. PubMed ID: 11219482
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
Krakoff LR; Bravo EL; Tuck ML; Friedman CP
Am J Hypertens; 1990 Dec; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
[TBL] [Abstract][Full Text] [Related]
7. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
Houston MC; Olafsson L; Burger MC
Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
[TBL] [Abstract][Full Text] [Related]
8. The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group.
Zanchetti A
Drugs; 1994; 48 Suppl 1():23-30; discussion 30-1. PubMed ID: 7533703
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
Toal CB
Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system.
Gavras I; Mulinari R; Gavras H; Higgins JT; Reeves RL; Zawada ET; Crook J; Halperin AK; Garrett B
Am J Med; 1987 Dec; 83(6B):20-3. PubMed ID: 3332575
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
Bravo EL; Krakoff LR; Tuck ML; Friedman CP
Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
[TBL] [Abstract][Full Text] [Related]
13. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
Zanchetti A
J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the Extended Release Adalat Canadian Trial (EXACT).
Toal CB; Mahon WA; Barnes C; Burelle D
Clin Ther; 1997; 19(5):924-35. PubMed ID: 9385481
[TBL] [Abstract][Full Text] [Related]
15. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
16. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension. Nifedipine Study Group.
Glasser SP; Ripa SR; Allenby KS; Schwartz LA; Commins BM; Jungerwirth S
Clin Ther; 1995; 17(2):296-312. PubMed ID: 7614530
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Palmer CR; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
Lancet; 2000 Jul; 356(9227):366-72. PubMed ID: 10972368
[TBL] [Abstract][Full Text] [Related]
20. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
